The effect of glycopyrrolate and a combined oxyphencyclimine-hydroxizine preparation on gastric acid secrection by Marks, I.N. et al.
THE EFFECT OF GLYCOPYRROLATE AND A COMBINED OXYPHENCYCLIMINE·
HYDROXIZINE PREPARATION ON GASTRIC ACID SECRETION
I. MARKS, B.Sc., M.B., F.R.C.P. (EDlN.), S. BANK, M.B., M.R.C.P. (LOND.), A. GROLL,* M.B., M.R.C.P. (LOND.)







:!9. \\'ood. P. (1956): Diseases of the Heart and Circulation. London:
Eyre & Spouiswoode.
30. Goodwin, l. F., Hunter. l. D., Cleland, W. P., Davies, L. G. and
Steiner, R. E. (1955): Brit. Med. J., 2, 573.
31. \\liI500, M. G. (1962): Advances in Rheumatic Fever, 1940-1961. lew
York: Harper & Row.
32. Bland, E. F. and Jones, T. D. (1951): Circulation. 4. 836.
33. Jhaveri, S.. Czoniczer, G., Reider, R. B. and MasselJ. B. F. (1960):
Ibid., 22, 39.
34. Wilson, M. G. (1962): Progr. Cardiovasc. Dis., 5, 145.
35. Wood, P. (1956): Op. cit ..'" p. 504.
36. Linde. L. M., Harper, J. A., Chuang, K. A. and Mulder. D. G.
(1965): J. Thorac. Cardiovasc. Surg., 3, 49.
37. Effler, D. B. (1962): Cleveland Clin. Quart.. 29, 167.
38. Braunwald, N. S., Cooper, T. and Morrow, A. G. (1960): J. Thorac.
Cardiovasc. Surg., 40, 1.
39. Levy. J.. Varco, R. L., Lillehei. C. W. and Edwards. J. L. (1963):
Ibid., 45, 434.
40. Spencer, F. C. (1963): Ann. Surg.. 158, 595.
41. SrarnJer, J. (1962): Amer. J. Cardiol., 10, 319.
42. Stam!er. R. and Stamler, J. (1962): Ibid., 10, 319.
43. Paul, J. R. (1957): The Epidemiology of Rheumatic Fever. ew
York: American Heart Association.
44. Logan, A. and Turner, R. (1953): Lancet. 1, 1007 and 1057.
45. Bailey. C. P. and Bolton, H. E. (1956): N.Y. Med. J., 56, 825.
46. Angelino, P. F., Levi, V., Brusca, A. and Actis-Dato. A. (1956):
Amer. Heat! J., 51, 916.
47. Glover. R. P. (1959): Amer. J. Cardiol., 4, 132.
Fig. I. Effect of varying doses of glycopyrrolate (Robinul)
on basal secretion and the MAO. The dose was adminis-
tered twice daily (I dose = 1·0 mg.).
RESULTS
output was calculated from the output of 'total' acid during
the hour preceding the injection of histamine and the maximal
acid output (MAO) from the output of 'total' acid during the
hour following the injection of histamine. Only these mea-
sures of acid secretion were employed in the present paper.
Subsequent augmented histamine tests were carried out after
the administration of a given dosage of one of the anticholi-
nergic preparations for a period of 3 days. The preparation
was given orally at 8 a.m. and 8 p.m., except on the morning
of the test when it was given 3 hours before the test was due
to start. Ten of the 30 patients were tested with 2 or 3 anti-
cholinergic preparations and a further 2 were tested on 2
occasions with the same preparation. The remaining 18
patients were tested on only one occasion with either Robinul
or Enarax.
Glycopyrrola;e (Robinul)
Robinul was tested in 15 patients, six of whom were
investigated on more than one occasion. The dose of
Robinul employed in these patients ranged from 1 to 3
mg. b.d. The results of the 22 tests carried out in the 16
patients are illustrated in Fig. I and the mean reduction in
basal secretion and the MAO with the different dosage
levels of Robinul presented ID Table I.
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METHOD
Twenty-seven patients were used for the present study.
Twenty-four of these had duodenal ulcers, I a gastric ulcer
and 2 a functional dyspepsia. Their ages ranged between 17
and 55 years.
Each patient underwent 2 - 5 augmented histamine tests,
which included a control test and tests carried out during a
course of treatment with one or more of the following anti-
cholinergic agents: Glycopyrrolate (Robinul) in a I, 2 or 3 mg.
b.d. dosage level, a combination preparation of 5 mg. oxy-
phencyclimine and 10 mg. hydroxizine (Enarax) in a I, 2 or 3
tabs. b.d. dosage level and propantheline (Pro-banthine P.A.)
in a 30 mg. b.d. dosage level. A total of 81 tests were carried
out in the 30 patients.
The augmented histamine test was carried out as previously
described.' After an overnight fast, a tube was introduced
through the nose and passed into the stomach. Under fluoro-
scopic control, the tip of the tube was adjusted to lie in the
most dependent part of the stomach. The fasting contents were
aspirated and the patient allowed to lie comfortably on his
back or on his left side. Throughout the test a vacuum of
30 - 50 mm.Hg was applied to the tube, in order to maintain
continuous aspiration, interrupted only by occasional manual
aspiration of gastric contents with a syringe to ensure com-
plete collections. The patient was urged to expectorate any
saliva accumulating in the mouth. Gastric contents were
aspirated for I hour before and I hour following the adminis-
tration of histamine acid phosphate (0·04 mg.jkg. body-
weight, given subcutaneously). Fifty mg. of mepyramine
maleate (Anthisan) was given by intramuscular injection, 30
minutes before the injection of histamine. Aliquots of the
basal and post-histami ne collections were titrated with N j 10
TaOH using Topfers reagent and phenolphthalein as indica-
tors for 'free' and 'total' acid, respectively. The basal acid
In the medical management of peptic ulcer, great empha-
sis is placed on the neutralization or inhibition of gastric
acid secretion. Antacid preparations are of unquestionable
value in the transient reduction of gastric acidity, but it is
generally agreed that anticholinergic drugs are required
to achieve a more uniform suppression of the acidity of
the gastric contents. The present study was undertaken to
investigate the antisecretory effect of two recently available
anticholinergic preparations on gastric secretIOn.
"Present address: University of Alabama. Birmingham. Alabama, USA.
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TABLE I. EFFECT OF VARIOUS ANTICHOLINERGIC PREPARATIONS ON
GASTRIC SECRETIO EXPRESSED I' TERMS OF MEAN PERCENTAGE
REDUCTION OF BASAL SECRETION AND MAO
Fig. 2. Effect of varying doses of oxypbencyclimine-hy-
droxizine (Enarax) on basal secretion and the MAO. The
dose was administered twice daily (1 dose = 5 mg. oxy-
phencyclimine + 10 mg. hydroxizine).
% redu<·tion ill MAO% reduction ill basal secrnion
Pro- Pro-
banthine Robillul Enarax banchine Robillu{ Enarax
P.A. P.A.
No. of tablets
glrell h.d. I I 2 3 I 2 3 I I 3 I 2 3
74 0 78 10 30 34
48 25 85 I 49 47
91 62 100 100 76 61 67 67
80 75 16 0
36 74 91 20 52 54
0 43 74 22 65 58 24 53 60 58
25 60 40 34 27 34
57 66 48 39
0 50 38 25
36 32 19 32
TABLE 11. COMPARISON OF PERCENTAGE REDUCTION IN BASAL
SECRETION A D MAO IN GROUP OF PATIENTS GIVE' MORE THAN I
ANTICHOLI ERGIC PREPARATION
dose levels of Robinul and En-arax was comparable with
that of the Pro-banthine P.A. and that the larger doses
tended to be more effective than the 30 mg. Pro-ban thine
preparation. This was supported by the data in Table 1
regarding the mean reduction in acid secretion on the 7
patients tested with Pro-banthine P.A. The mean reduction
in basal secretion in this small group was 51 0 0 and the
mean reduction in MAO, 31 0 0. Two of these 7 patients
admitted to dryness of the mouth while on Pro-banthine.
The data in Table 11 show, in addition, that the anti-
secretory effect of Robinul and Enarax was comparable
on a tablet-for-tablet basis. However, the number of
patients in :his sub-group was too small to permit of a
definite conclusion.
The mean reduction in basal secretion ranged from 43'\,
with the tabs. 1 b.d. dose to 66 0 0 with the tabs. 3 b.d.
dose and the mean reduction in MAO ranged from about
40 0 0 with the smaller dose to 4ro with the larger dose.
Dryness of the mouth was troublesome in 1 of the 4
patients on the tabs. 3 b.d. dose but in none of the patients
on the maller do es and was present to a lesser degree in
2 of the remaining 18 patients. The tranquillizing effect
of the hydroxizine (Aterax) was difficult to assess because
of the shortness of the trial periods but none of the
patient complained of undue lassitude or tiredness.
Comparison 'J! Robinul, Enarax and Pro-balllhine P.A.
The antisecretory effect of different doses of Robinul
and Enarax was compared with the effect of propantheline
(Pro-ban thine P.A., 30 mg.) in 7 patients and a further 3
patients were investigated with both Robinul and Enarax.
Table II shows that the antisecretory effect of the single
DISCUSSiON
The present study confirmed the efficacy of glycopyrrolate
(Robinul) and a combined oxyphencyclimine-hydroxizine
preparation (Enarax) in the reduction of gastric acid
secretion.'·' Tt showed, in addition, that both basal secre-
tion and the response to maximal histamine stimulation
were affected. Basal secretion was reduced to a greater
extent than was the MAO in the majority of patients and
the antisecretory effect of even the lower dosage levels of
these preparations was comparable to that found following
the administration of a 30 mg. dose of a prolonged-action
preparation of propantheline. Side-effects were minimal or
absent with effective antisecretory dosages of glycopyrro-
late or Enarax, but it should be noted that no elderly





Number Mean % reduCTion
PreparaTion Dose of paTients and range
Basal MAO
r 1 b.d. 7 49 (0-75) 38 (0-71)
Robinul ~ 2 b.d. 13 59 (0-85) 45 (19-73)
~ 3 b.d. 2 61 (22-100) 64 (60-67)
1 b.d. 5 42 (7-75) 40 (0-79)
Enarax ~ 2 b.d. 13 46 (0-76) 38 (0-66)
l 3 b.d. 4 66 (46--91) 47 (39-54)
Pro-banthine P.A.
(30 mg.) J b.d. 7 51 (0-80) 31 (1-76)
There were marked VariatIOns in the magnitude of the
reduction of basal secretion and the MAO with all dosage
levels employed, but the data in Table I indicate that the
larger dosage levels suppressed both basal secretion and
the MAO more effectively than did the smaller doses. The
mean reduction in basal secretion ranged from 49~0 with
the I mg. dose to 61 0 " with the 3 mg. dose and the mean
reduction in MAO varied between 38 0 0 with the smaller
and 64 0 0 with the larger dose.
Side-effects were experienced in patients during 4 of the
22 tests. One of the 7 patients on a I mg. b.d. dosage level,
2 of the 13 patients on a 2 mg. b.d. dosage level and 1 of
the 2 on a 3 mg. b.d. dosage level had slight dryness of
the mouth. More serious side-effects were not encountered.
Oxyphencyclimine-Hydroxizine (Enarax)
Twenty-two tests with Enarax were carried out in 19
patients. The dose of Enarax employed ranged from I to 3
tablets b.d. The data on these and the respective control
tests are illustrated in Fig. 2 and the mean reduction in
basal secretion and the MAO with the different dosage
levels of Enarax are presented in Table 1.
Marked variations in the percentage reduction in basal
secretion and MAO were again noted for each of the 3
dosage levels, the larger doses tending to suppress basal
ecretion and MAO more effectively than the smaller ones.
--
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The antisecretory effect of Robinul was perhaps slightly
greater than that of Enarax on a tablet-for-tablet basis.
Enarax. however, has the advantage of having a long
duration of action'" and in addition, of containing a 10
mg. dose of Aterax. The latter, with its central sedative.
antisecretory and antispasmodic action has been claimed
to be a useful adjunct to anticholinergic therapy in the
treatment of peptic ulceration and functional bowel dis-
order.'·lo
It should be stressed that the dosage schedule of one or
more tablet administered twice daily was an arbitrary
one, employed only for purposes of the present trial, and
that the data regarding suppression of gastric secretion
were derived from tests commenced exactly 3 hours
following a given dose of one of the preparations. The
present paper does not provide information on the number
of doses required to produce adequate suppression of
acid secretion over a 24-hour period, but available data
suggest that this may be achieved with Enarax adminis-
tered every 8 or 12 hours or with Robinul given at 6 to
-hourly intervals.
The marked variations in the effect of a given dose of
an anticholinergic preparation observed in different
patients lends support to the concept, championed by Sun
and Shay," regarding the importance of the optimum
effective dose (QED) in the management of peptic ulcera-
tion. They suggest that the QED be determined for each
patient by gradually increasing the dose of drug to a level
of one increment below that which produces uncomfort-
able symptoms of parasympathetic inhibition. The relative
absence of these side-effects in the majority of patients in
the present study suggested that the dosages employed
were generally below the QED and that at least some of
the patients would have tolerated a larger dose of the
anticholinergic preparation than that employed. Since the
degree of inhibition in acid secretion increased with an
increase in the dose of drug, this would have allowed the
patients to have been given an even more effective dose
of anticholinergic preparation.
SUMMARY
Glycopyrrolate (Robinul) and oxyphencyciirnine HCI-hydroxi-
zine (Enarax), 2 recently available anticholinergic prepara-
tions, have been shown to result in an appreciable reduction
in basal and histamine-induced acid secretion, with dose levels
producing little or no side-effects.
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SEPTIC ARTHRITIS
c. S. B. GALASKO,* M.B., B.CH. (RAND), Department of Onhopaedic Surgery, Johannesburg Hospirat
and University of the Witwatersrand, Johannesburg
The incidence of septic arthritis is no less today than in
the pre-antibiotic era, but that of chronic arthritis is less:
In the pre-antibiotic era the development of a painless,
ankylosed joint was considered a good result. Very few re-
tained a fully functional painless joint. Destruction of the
joint, pathological dislocation and a painful fibrous anky-
losis were common sequelae.
Today two-thirds of cases have a satisfactory outcome
with simple measures such as rest and antibiotics.' In the
other cases the infection becomes suppressed by the anti-
biotics and a subacute arthritis develops which may flare
up into an acute attack as soon as antibiotic therapy is dis·
continued. The eau ative organisms eventually tend to be-
come in ensitive to the antibiotics used.
In an attempt to avoid this long drawn-out course with
frequent exacerbations, a number of procedures have been
used. The joint may be aspirated. This relieves tension on
the joint ligaments and hence reduces pain. It also enables
one to culture the causative organism and to ascertain its
antibiotic sensitivity. At the same time one may instil anti-
biotics, usually penicillin, into the joint. It has been shown
that most antibiotic. with the exception of crystalline
·Present address: Royal College of .. urgeons of England, Lincoln's Inn
Fields. London.
penicillin, do not cross the normal or traumatized joint
lining.' As the causative organism is lying within the joint's
synovial fluid, it is exposed to a much higher concentra-
tion of antibiotics by direct instillation into the joint.
Soto-Hall el at.' have shown that increasing the intra-
articular pressure in the hip, possibly because of its rather
unique arterial blood supply, may cause an avascular ne-
crosis of the head of the femur. Aspiration will relieve the
tension in the affected joint and hence avoid this possible
compi ication.
Repeated aspirations, with or without simultaneous in-
stillation of antibiotics, have also been used, especial1y if
the effusion tends to recur. Jergeson and Jawitz' insert a
tube via a trocar into the affected joint and then instil
antibiotics 12-hourly into the joint. This is left undisturbed
for 3 hours and then the tube is connected to suction
drainage until the next instillation.
Watkins' prefers open operation and incision and drain-
age of the affected joint. If there is a lot of purulent fluid
present, he finds no contraindications to maintaining an
intra-articular drain for up to 4 - 7 days.
In the past few months we have used continuous per-
fusion of joints in 3 cases. all 3 affecting the knee, with
very gratifying results.
